Novozymes closes majority stake acquisition of Synergia
Danish firm Novozymes, which is specialized in enzymes, has closed the transaction of the majority stake in Synergia Life Sciences, which is based in India.
by andreas lønstrup, translated by daniel pedersen
Danish enzymes company Novozymes has completed the purchase of the majority stake in Indian biotech firm Synergia Life Sciences, it reports in a press release on Friday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
